449.95MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Ovid Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 39.21%, representing a quarter-over-quarter increase of 16.68%. The largest institutional shareholder is Steven Cohen, holding a total of 1.15M shares, representing 0.87% of shares outstanding, with 22.95% increase in holdings.
Institutional Shareholding
Shareholder Activity
RA Capital Management, LP
Takeda Pharmaceutical Co Ltd
Affinity Asset Advisors LLC
Adar1 Capital Management LLC
Eventide Asset Management, LLC
Federated Hermes Global Investment Management Corp.
Adage Capital Management, L.P.